Agrenvec/Anti-Human LXR beta (Serum) – RF0021/RF0021/1 Ea
其他免疫產(chǎn)品
商品編號
RF0021
品牌
Agrenvec
公司
Agrenvec
公司分類(lèi)
Anti-Human Polyclonal Serum
Size
1 Ea
商品信息
Description:
?Rabbit Polyclonal Antibody?Serum to LXR beta
Application:
?WB
Reactivity:
?Human
Conjugate:
Unconjugated
ELISA
:
?No data available.
Western Blot
:
?Suggested starting dilution 1/10,000. Anti-rabbit IgG-AP (alkaline phosphatase conjugate) is recommended as secondary reagent.
Description:
?Anti-Human LXR beta Serum is developed in rabbit using recombinant human LXR beta produced in plants.
Immunogen:?
Highly pure (>97%) recombinant human LXR beta L
BD
(ligand binding domain) expressed in plants.
Applications:
ELISA
:
?No data available.
Western Blot
:
?Suggested starting dilution 1/10,000. Anti-rabbit IgG-AP (alkaline phosphatase conjugate) is recommended as secondary reagent.
Fig 1. Western Blot analysis of rhuman LXR beta using Anti-Human LXR beta Serum (RF0021)
Human LXR?? protein was resolved by SDS-PAGE, transferred to a NC membrane and probed with a dilution 1:6,000 of Anti-Human LXR beta Serum. Anti-rabbit IgG-AP (alkaline phosphatase conjugate) was used as secondary reagent. Lane 1: MWM; Lane 2: 250 ng of rHuman LXR beta full-length protein; Lane 3: empty lane; Lane 4: 250 ng of rHuman LXR beta-Ligand Binding Domain (
Agrenvec
RF0019).
Where this antibody has not been tested for use in a particular technique this not necessarily excludes its use in such procedures.
Optimal dilution conditions should be determined by the final user.
Bulk sizes are available upon request. For R&D purposes only.
Purchaser must determine the suit
ABI
lity of the product(s) for their particular use.
產(chǎn)品貨號:1916.0